Projects per year
Abstract
Pharmacologic inhibition of the protein-protein interaction (PPI) interface of the Keap1:Nrf2 complex, which leads to Nrf2 activation and cytoprotective gene expression, offers a promising strategy for disease prevention and treatment. To facilitate identification and validation of small-molecule Keap1:Nrf2 PPI inhibitors in the cellular environment in a low- and medium-throughput manner, we detail two adapted cellular thermal shift assay (CETSA) protocols, Keap1-CETSA, an immunoblotting-based methodology for detecting endogenous Keap1, and Keap1-Glow CETSA, a microtiter plate assay of overexpressed fluorescently-tagged Keap1. For an example of the use and execution of this protocol, please refer to Dayalan Naidu et al. (2021).
Original language | English |
---|---|
Article number | 101265 |
Number of pages | 17 |
Journal | STAR Protocols |
Volume | 3 |
Issue number | 2 |
Early online date | 1 Apr 2022 |
DOIs | |
Publication status | Published - 17 Jun 2022 |
Keywords
- Cell Biology
- Cell culture
- Cell-based Assays
- Molecular Biology
Fingerprint
Dive into the research topics of 'Detection of thermal shift in cellular Keap1 by protein-protein interaction inhibitors using immunoblot- and fluorescence microplate-based assays'. Together they form a unique fingerprint.Projects
- 3 Finished
-
Method Development for Quantitative Assessment of Protein Turnover in Live Cells at Subcellular Resolution
Dinkova-Kostova, A. (Investigator), Muqit, M. (Investigator) & Saurin, A. (Investigator)
1/03/18 → 31/12/19
Project: Research
-
The Role of the Keap1/Nrf2 Pathway in Tumour Metabolic Adaptation (Joint with University of Cambridge and University College London)
Dinkova-Kostova, A. (Investigator)
1/06/15 → 30/04/21
Project: Research
-
The Spatiotemporal Regulation of the Keap1/Nrf2 Pathway (Joint with University College London)
Dinkova-Kostova, A. (Investigator)
Biotechnology and Biological Sciences Research Council
30/09/14 → 27/02/18
Project: Research